✦ LIBER ✦

Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

✍ Scribed by Masato Sakon; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Koji Umeshita; Akira Yamada; Sumio Kawata; Yasuharu Imai; Shohei Iijima; Morito Monden

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 417 KB
Volume: 94
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.10246

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sakon M, Nagano H, Dono K, Nakamori S, U

Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, Kawata S, Imai Y, Iijima S, Monden M. Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer. 2002;94(2):435–42.

📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

## Abstract The original article to which this Erratum refers was published in Cancer (2002) 94(2):435–42

Combination therapy of intraarterial 5-f

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

✍ Shuntaro Obi; Haruhiko Yoshida; Risa Toune; Tadao Unuma; Miho Kanda; Shinpei Sat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

Interferon-α and 5-fluorouracil combinat

Interferon-α and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules

✍ Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Hideo Ota; Shigeru Marubashi; Yu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

## Abstract ## BACKGROUND. The authors reported previously the beneficial effects of interferon (IFN)‐α/5‐fluorouracil (5‐FU) combination therapy for patients with advanced hepatocellular carcinoma (HCC) who have tumor thrombi in the major portal branches. In this report, the authors describe the

Combined therapy consisting of intraarte

Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-α for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

✍ Young-Hwa Chung; Il Han Song; Byung-Cheol Song; Geun Chan Lee; Moon Soo Koh; Hyu 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## BACKGROUND. Hepatocellular carcinoma (HCC) patients with major vascular involvement or extrahepatic metastasis are not good candidates for surgery or transarterial chemoembolization (TACE). In this study, the authors evaluated the efficacy of combined therapy with intraarterial cisplatin infusio